Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REAL: Letrozole Tolerability After Anastrozole Discontinuation
NCT00688909Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2008
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of letrozole in breast cancer, sponsored by Novartis. Started Mar 2008; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00688909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00688909.